Physicians and patients agree: new technology will improve Vascular Health

Bangalore, Aug. 24, 2020:New global market research,released today from Abbott, takes a deep dive into the barriers of cardiovascular patient care and shows that more than 80% of physicians and hospital administrators view technology and data as critical toaddressing challenges before, during and after treatment.
According to the new data, 79% of patients have confidence in physicians'decision-making, but they feel technology can help deliver more personalized care. More than half of vascular patients globally believe that utilizing the latest diagnostic and treatment technologies canhelp physiciansdetermine the besttreatment plan. 
The findings fromBeyond Intervention, a report commissionedby Abbott,show that using advanced technologies can enable more precise diagnoses and better treatment strategies to ensure the best possible results.  The Survey was designed to examine the current state of vascular care and how health care leaders, physicians and patients view the importance of incorporating data and technology into treatment pathways.
"Technological advances can help providers select and treat the right patients, at the right time, with the right approach, thereby easing the burden on patients, healthcare workers and healthcare systems," said Nick West M.D., chief medical officer and divisional vice president of Medical Affairs at Abbott’s vascular business. "This research identifies how physicians and administrators can improve patient care—and the need for the right use of technology and data to enable more precise diagnoses, informed decisions and determine better treatment strategies to ensure the best possible patient health."
Innovating New Solutions Based on Clinical Need
Cardiovascular disease (CVD) remains the leading cause of death worldwide, but with proper interventions and post-procedural care,up to 80% of CVD-related deaths may be preventable. In India, CVD is the leading cause of mortality.
According to the Global Burden of Disease study, the estimate of age-standardized CVD death rate of 272 per 100,000 population in India is higher than the global average of 235 per 100,000 population. To better understand growingtreatment gaps in cardiovascular healthcare and identify new ways to continue addressing existing challenges, Abbott commissioned the Beyond Intervention survey to capture feedback from more than 1,400 physicians, health system administrators and patientsto uncover their views on how data and technology could better guide physician decision making and improve patient outcomes.